Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-03-15 09:00 am Unchanged | 13D | ENTASIS THERAPEUTICS HLDGS INC ETTX | Innoviva Inc. INVA | 57,345,794 74.93% | 0 (Unchanged) | View |
| 2022-02-18 8:47 pm Unchanged | 13D | ENTASIS THERAPEUTICS HLDGS INC ETTX | Innoviva Inc. INVA | 57,345,794 75.15% | 0 (Unchanged) | View |
| 2022-02-11 3:15 pm Purchase | 13D | ARMATA PHARMACEUTICALS INC ARMP | Innoviva Inc. INVA | 36,363,604 76.7% | 5,422,188 (+17.52%) | View |
| 2022-02-11 2:10 pm Sale | 13G | INNOVIVA INC INVA | RENAISSANCE TECHNOLOGIES LLC | 5,295,133 7.62% | -2,196,209 (-29.32%) | View |
| 2022-02-10 08:17 am Purchase | 13G | INNOVIVA INC INVA | VANGUARD GROUP INC | 6,800,195 9.79% | 204,712 (+3.10%) | View |
| 2022-02-01 6:34 pm Unchanged | 13D | ENTASIS THERAPEUTICS HLDGS INC ETTX | Innoviva Inc. INVA | 57,345,794 75.15% | 0 (Unchanged) | View |
| 2022-02-01 1:48 pm Purchase | 13G | INNOVIVA INC INVA | WESTFIELD CAPITAL MANAGEMENT CO LP | 3,683,485 5.3% | 3,683,485 (New Position) | View |
| 2022-01-28 1:54 pm Sale | 13G | INNOVIVA INC INVA | BlackRock Inc. BLK | 9,008,758 13% | -2,151,788 (-19.28%) | View |
| 2021-11-01 09:27 am Purchase | 13D | ARMATA PHARMACEUTICALS INC ARMP | Innoviva Inc. INVA | 30,941,416 73.8% | 30,941,416 (New Position) | View |
| 2021-06-11 5:37 pm Purchase | 13D | ENTASIS THERAPEUTICS HLDGS INC ETTX | Innoviva Inc. INVA | 57,345,794 75.5% | 12,537,950 (+27.98%) | View |
| 2021-06-07 4:43 pm Sale | 13G | INNOVIVA INC INVA | RENAISSANCE TECHNOLOGIES LLC | 7,491,342 10.79% | -390,460 (-4.95%) | View |
| 2021-05-25 5:05 pm Unchanged | 13D | INNOVIVA INC INVA | Sarissa Capital Management LP | 6,414,000 9.24% | 0 (Unchanged) | View |
| 2021-05-25 4:24 pm Sale | 13D | INNOVIVA INC INVA | GSK plc GSK | 0 0% | -32,005,260 (Position Closed) | View |
| 2021-05-03 5:19 pm Purchase | 13D | ENTASIS THERAPEUTICS HLDGS INC ETTX | Innoviva Inc. INVA | 44,807,844 70.6% | 7,462,050 (+19.98%) | View |
| 2021-04-05 5:07 pm Sale | 13D | ARMATA PHARMACEUTICALS INC ARMP | Innoviva Inc. INVA | 0 0% | -29,729,294 (Position Closed) | View |
| 2021-03-17 5:17 pm Purchase | 13D | ARMATA PHARMACEUTICALS INC ARMP | Innoviva Inc. INVA | 29,729,294 74.7% | 8,571,870 (+40.51%) | View |
| 2021-02-12 5:13 pm Unchanged | 13D | INNOVIVA INC INVA | GSK plc GSK | 32,005,260 31.6% | 0 (Unchanged) | View |
| 2021-02-11 09:42 am Sale | 13G | INNOVIVA INC INVA | RENAISSANCE TECHNOLOGIES LLC | 7,881,802 7.77% | -11,895 (-0.15%) | View |
| 2021-02-10 11:03 am Sale | 13G | INNOVIVA INC INVA | VANGUARD GROUP INC | 6,595,483 6.5% | -211,456 (-3.11%) | View |
| 2021-01-27 5:30 pm Purchase | 13D | ARMATA PHARMACEUTICALS INC ARMP | Innoviva Inc. INVA | 21,157,424 68% | 3,735,824 (+21.44%) | View |